HAYWARD, Calif. & CAMBRIDGE, England & IPSWICH, Mass.--(BUSINESS WIRE)--Aug. 1, 2006--Solexa, Inc. (Nasdaq:SLXA) today announced that it has reached an agreement with New England Biolabs Inc. (NEB), a leading supplier of enzymes and technologies to the life science market, for NEB to provide Solexa with certain key enzymes and other reagents for use with the Solexa Genome Analysis System. Under the terms of this agreement, NEB will also manufacture Solexa’s proprietary sequencing-by-synthesis polymerase. Financial terms of the agreement were not disclosed.
